Publications by authors named "Noa Bossel"

Understanding the tradeoffs faced by organisms is a major goal of evolutionary biology. One of the main approaches for identifying these tradeoffs is Pareto task inference (ParTI). Two recent papers claim that results obtained in ParTI studies are spurious due to phylogenetic dependence (Mikami T, Iwasaki W.

View Article and Find Full Text PDF

Sperm-associated antigen 5 (SPAG5) is an important driver of the cell mitotic spindle required for chromosome segregation and progression into anaphase. SPAG5 has been identified as an important proliferation marker and chemotherapy-sensitivity predictor, especially in estrogen receptor-negative breast cancer subtypes. Here, we report that SPAG5 is a direct target of miR-10b-3p, and its aberrantly high expression associates with poor disease-free survival in two large cohorts of breast cancer patients.

View Article and Find Full Text PDF

Tumor relapse as a consequence of chemotherapy resistance is a major clinical challenge in advanced stage breast tumors. To identify processes associated with poor clinical outcome, we took a mass spectrometry-based proteomic approach and analyzed a breast cancer cohort of 113 formalin-fixed paraffin-embedded samples. Proteomic profiling of matched tumors before and after chemotherapy, and tumor-adjacent normal tissue, all from the same patients, allowed us to define eight patterns of protein level changes, two of which correlate to better chemotherapy response.

View Article and Find Full Text PDF
Article Synopsis
  • - EGF triggers changes in gene expression that are often disrupted in cancer, and microRNAs play a significant role in this process by regulating messenger RNAs.
  • - Research found that EGF stimulation leads to the coordinated activity of microRNAs and transcription factors, starting with a decrease in 23 specific microRNAs.
  • - This reduction in microRNAs allows for the quick activation of oncogenic transcription factors like c-FOS, and is linked to lower levels of these microRNAs in certain tumors associated with EGFR and HER2.
View Article and Find Full Text PDF